251 related articles for article (PubMed ID: 10510332)
1. VEGF(165) mediates glomerular endothelial repair.
Ostendorf T; Kunter U; Eitner F; Loos A; Regele H; Kerjaschki D; Henninger DD; Janjic N; Floege J
J Clin Invest; 1999 Oct; 104(7):913-23. PubMed ID: 10510332
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
[TBL] [Abstract][Full Text] [Related]
3. A study of VEGF and its receptors in two rat models of proteinuria.
Kanellis J; Levidiotis V; Khong T; Cox AJ; Stacker SA; Gilbert RE; Cooper ME; Power DA
Nephron Physiol; 2004; 96(1):P26-36. PubMed ID: 14752241
[TBL] [Abstract][Full Text] [Related]
4. Extracellular actin impairs glomerular capillary repair in experimental mesangioproliferative glomerulonephritis.
Janssen U; Eitner F; Kunter U; Ostendorf T; Wolf G; Chaponnier C; Gabbiani G; Kerjaschki D; Floege J
Nephron Exp Nephrol; 2003; 93(4):e158-67. PubMed ID: 12759577
[TBL] [Abstract][Full Text] [Related]
5. A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects.
van Roeyen CR; Boor P; Borkham-Kamphorst E; Rong S; Kunter U; Martin IV; Kaitovic A; Fleckenstein S; Perbal B; Trautwein C; Weiskirchen R; Ostendorf T; Floege J
Am J Pathol; 2012 May; 180(5):1979-90. PubMed ID: 22538190
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.
Kim YG; Suga SI; Kang DH; Jefferson JA; Mazzali M; Gordon KL; Matsui K; Breiteneder-Geleff S; Shankland SJ; Hughes J; Kerjaschki D; Schreiner GF; Johnson RJ
Kidney Int; 2000 Dec; 58(6):2390-9. PubMed ID: 11115072
[TBL] [Abstract][Full Text] [Related]
7. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
Keller K; Daniel C; Schöcklmann H; Endlich KH; Kerjaschki D; Johnson RJ; Hugo C
Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
9. [VEGF is an essential molecule for glomerular endothelial cells and its excretion in urine might be a unique marker of glomerular injury].
Kitamoto Y; Tokunaga H; Miyamoto K; Tomita K
Rinsho Byori; 2000 Jun; 48(6):485-90. PubMed ID: 10897664
[TBL] [Abstract][Full Text] [Related]
10. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H
Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
[TBL] [Abstract][Full Text] [Related]
11. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis.
Iruela-Arispe L; Gordon K; Hugo C; Duijvestijn AM; Claffey KP; Reilly M; Couser WG; Alpers CE; Johnson RJ
Am J Pathol; 1995 Dec; 147(6):1715-27. PubMed ID: 7495296
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo.
Hugo CP; Pichler RP; Schulze-Lohoff E; Pröls F; Adler S; Krutsch HC; Murphy-Ullrich JE; Couser WG; Roberts DD; Johnson RJ
Kidney Int; 1999 Jun; 55(6):2236-49. PubMed ID: 10354272
[TBL] [Abstract][Full Text] [Related]
13. PDGF-C mediates glomerular capillary repair.
Boor P; van Roeyen CR; Kunter U; Villa L; Bücher E; Hohenstein B; Hugo CP; Eriksson U; Satchell SC; Mathieson PW; Eitner F; Floege J; Ostendorf T
Am J Pathol; 2010 Jul; 177(1):58-69. PubMed ID: 20489153
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of capillary repair in proliferative glomerulonephritis results in persistent glomerular inflammation with glomerular sclerosis.
Masuda Y; Shimizu A; Kataoka M; Arai T; Ishikawa A; Du X; Saito SK; Aki K; Nagasaka S; Mii A; Fujita E; Fukuda Y
Lab Invest; 2010 Oct; 90(10):1468-81. PubMed ID: 20644521
[TBL] [Abstract][Full Text] [Related]
15. Recovery of damaged glomerular capillary network with endothelial cell apoptosis in experimental proliferative glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Nephron; 1998; 79(2):206-14. PubMed ID: 9647502
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.
Suga S; Kim YG; Joly A; Puchacz E; Kang DH; Jefferson JA; Abraham JA; Hughes J; Johnson RJ; Schreiner GF
Kidney Int; 2001 Oct; 60(4):1297-308. PubMed ID: 11576344
[TBL] [Abstract][Full Text] [Related]
17. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis.
Uchimura H; Marumo T; Takase O; Kawachi H; Shimizu F; Hayashi M; Saruta T; Hishikawa K; Fujita T
J Am Soc Nephrol; 2005 Apr; 16(4):997-1004. PubMed ID: 15744001
[TBL] [Abstract][Full Text] [Related]
18. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
Kunter U; Rong S; Djuric Z; Boor P; Müller-Newen G; Yu D; Floege J
J Am Soc Nephrol; 2006 Aug; 17(8):2202-12. PubMed ID: 16790513
[TBL] [Abstract][Full Text] [Related]
19. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
[TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety.
Burg M; Ostendorf T; Mooney A; Koch KM; Floege J
Lab Invest; 1997 Apr; 76(4):505-16. PubMed ID: 9111513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
